Björklund Pharma

  • Home
  • Company
  • Science & Innovation
  • Media
  • Contact
    • Contact Form

Science & Innovation

Björklund Pharma is an early-stage biotechnology company, which specializes in the following therapeutic areas:

  • Immune System
  • Cardiovascular and Metabolic Health
  • Brain and Nervous System
  • Eye Health
  • Bone, Muscle, and Joint Health
  • Skin Health
  • Nutraceuticals

Recent Posts

  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment
  • Zinc Deficiency: A Globally Widespread Ailment
  • Serum Zinc and Copper Levels in Autistic Children

Company News

  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment
  • Zinc Deficiency: A Globally Widespread Ailment
  • Serum Zinc and Copper Levels in Autistic Children
  • Email
  • Facebook
  • Google+
  • LinkedIn
  • Twitter
  • YouTube

RSS CONEM News

  • Better Brain Health – We Are What We Eat
  • Nutritional Minerals and the Periodic Table
  • Semey Revisited: The legacy of nuclear testing in Kazakhstan
  • Environmental Radiation Exposure and Essential Hypertension in Semey, Kazakhstan
  • A Brief History of Fat, and Why We Hate It

Contact Us

Björklund Pharma AS
Toften 24
8610 Mo i Rana
Norway

Phone: +47 411 11 942
Email: info(at)bjorklundpharma.com

Copyright © 2022 Björklund Pharma AS